Measures of genotoxicity in Gulf war I veterans exposed to depleted uranium

Environmental and Molecular Mutagenesis

Volumn 52, Issue 7, 2011, Pages 569-581

  Mcdiarmid, Melissa A ^a   Albertini, Richard J ^b   Tucker, James D ^c   Vacek, Pamela M ^b   Carter, Elizabeth W ^b   Bakhmutsky, Marina V ^c   Oliver, Marc S ^a   Engelhardt, Susan M ^d   Squibb, Katherine S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Biomarkers of genotoxicity; Depleted uranium; HPRT mutations; Human carcinogenicity

Indexed keywords

BIOLOGICAL MARKER; CREATININE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; URANIUM;

ADULT; ARTICLE; CARCINOGENICITY; CHROMOSOME ABERRATION; CLASTOGENICITY; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FREQUENCY ANALYSIS; GENOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTAGENICITY; MUTANT; MUTATION; OUTCOME ASSESSMENT; SPECTROSCOPY; URINALYSIS; VETERAN; WAR;

ADULT; ENVIRONMENTAL EXPOSURE; GULF WAR; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; URANIUM; VETERANS;

EID: 79960988109     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20658     Document Type: Article

References (78)

1. Albertini RJ, Hayes RB. 1997. Somatic mutations in cancer epidemiology. In: Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N, editors. Application of Biomarkers in Cancer Epidemiology, Vol. 142. IARC Scientific Publication. IARC, Lyon. pp 159-184.
2. Army Environmental Policy Institute (AEPI). 1995. Health and Environmental Consequences of Depleted Uranium Use in the US Army. Atlanta, GA: AEPI.
3. Au WW, Lane RG, Legator MS, Whorton EG, Wilkinson GS, Gabehart GJ. 1995. Biomarker monitoring of a population residing near uranium mining activities. Environ Health Perspect 103: 466-470.
4. Bakhmutsky MV, McDiarmid MA, Squibb K, Tucker JD. 2011. Long term depleted uranium exposure in Gulf War veterans does not cause elevated numbers of micronuclei in peripheral blood lymphocytes. Mutat Res: Genet Toxicol Environ Mutagen 720: 53-57.
5. Boice JDJr, Cohen SS, Mumma MT, Chadda B, Blot WJ. 2008. A cohort study of uranium millers and miners of Grants, New Mexico, 1979-2005. J Radiol Prot 28: 303-325.
6. Ceppi M, Biasotti B, Fenech M, Bonassi S. 2010. Human population studies with the exfoliated buccal micronucleus assay: Statistical and epidemiological issues. Mutat Res 705: 11-19.
7. Coryell VH, Stearn DM. 2006. Molecular analysis of HPRT mutations generated in Chinese Hamster Ovary EM9 cells by uranyl acetate, by hydrogen peroxide and spontaneously. Mol Carcinog 45: 60-72.
8. Cross FT, Palmer RF, Busch RH, Filipy RE, Stuart BO. 1981. Development of lesions in Syrian golden hamsters following exposure to radon daughters and uranium ore dust. Health Phys 41: 135-153.
9. Ejnik JW, Todorov T, Mullick FG, Squibb KS, McDiarmid MA, Centeno JA. 2005. Uranium analysis in urine by inductively coupled plasma dynamic reaction cell mass spectrometry. Anal Bioanal Chem 382: 73-79.
10. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. 2003. HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534: 65-75.
11. Gagnon DR, Doron-LaMarca S, Bell M, O'Farrell TJ, Taft CT. 2008. Poisson regression for modeling count and frequency outcomes in trauma research. J Traum Stress 21: 448-454.
12. Hando JC, Nath J, Tucker JD. 1994. Sex chromosomes, micronuclei and aging in women. Chromosoma 103: 186-192.
13. Hartsock WJ, Cohen JD, Segal DJ. 2007. Uranyl acetate as a direct inhibitor of DNA-binding proteins. Chem Res Toxicol 20: 784-789.
14. Hodge HC, Stannard JN, Hursh JB, editors. 1973. Handbook of Experimental Pharmacology: Uranium, Plutonium, Transplutonic Elements, Vol. 36. New York: Springer-Verlag.
15. Hooper FJ, Squibb KS, Siegel EL, McPhaul K, Keogh JP. 1999. Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys 77: 512-519.
16. Hueper WC, Zuefle JH, Link AM, Johnson MG. 1952. Experimental studies in metal carcinogenesis. II. Experimental uranium cancers in rats. J Natl Cancer Inst 13: 291-305.
17. Institute of Medicine. 2000. Gulf War and Health, Vol. 1. Washington, D.C.: National Academy Press.
18. Institute of Medicine. 2008. Gulf War and Health. Updated Literature Review of Depleted Uranium. Washington, D.C.: National Academy Press.
19. International Agency for Research on Cancer (IARC). 2006. Preamble to the IARC Monographs (amended January, 2006). Available at: Accessed: March 12, 2010.
20. Karpas Z, Kirber A, Eliah E, Marcus P, Roiz Y, Marko R, Kol R, Brikner D, Halicz L. 1998. Uranium in urine-Normalization to creatinine. Health Phys 74: 86-90.
21. Kathren RL, Moore RH. 1986. Acute accidental inhalation of U: A 38-year follow-up. Health Phys 51: 609-619.
22. Kathren RL, McInroy JF, Moore RH, Dietert SE. 1989. Uranium in the tissues of an occupationally exposed individual. Health Phys 57: 17-21.
23. Knobel Y, Glei M, Weise A, Osswald K, Schaferhenrich A, Richter KK, Claussen U, Pool-Zobel BL. 2006. Uranyl nitrilotriacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97. Toxicol Sci 93: 286-297.
24. Leach LJ, Maynard EA, Hodge HC, Scott JK, Yuile CL, Sylvester GE, Wilson HB. 1970. A five-year inhalation study with natural uranium dioxide (UO2) Dust-I. Retention and biologic effects in monkey, dog and rat. Health Phys 18: 599-612.
25. 2) Dust-II. Post exposure retention and biologic effect in the monkey, dog and rat. Health Phys 25: 239-258.
26. Leggett RW. 1989. The behavior and chemical toxicity of U in the kidney: A reassessment. Health Phys 57: 365-383.
27. Lin RH, Wu LJ, Lee CH, Lin-Shiau SY. 1993. Cytogenetic toxicity of uranyl nitrate in Chinese hamster ovary cells. Mutat Res 319: 197-203.
28. Lloyd DC, Lucas JN, Edwards AA, Deng W, Valente E, Hone PA, Moquet JE. 2001. A study to verify a reported excess of chromosomal aberrations in blood lymphocytes of Namibian uranium miners. Radiat Res 155: 809-817.
29. Long JS, Freese J. 2005. Regression Models for Categorical Outcomes Using Stata, 2nd ed. College Station, TX: Stata Press.
30. Martin F, Earl R, Tawn EJ. 1991. A cytogenic study of men occupationally exposed to uranium. Br J Ind Med 48: 98-102.
31. Maynard EA, Hodge HC. 1949. Studies of the toxicity of various uranium compounds when fed to experimental animals. In: Voegtlin IC, Hodge HC, editors. Pharmacology and Toxicology of Uranium Compounds. National Nuclear Energy Services (VI). New York, NY: McGraw-Hill. pp 309-376.
32. Maynard EA, Down WL, Hodge HC. 1953. Oral toxicity of uranium compounds. In: Voetglin C, Hodge HC, editors. Pharmacology and Toxicology of Uranium Compounds. New York, NY: McGraw-Hill. pp 1221-1369.
33. McDiarmid M, Squibb KS. 2001. Uranium and thorium. In: Bingham E, Cohrssen B, Powell C, editors. Patty's Industrial Hygiene and Toxicology, 5th ed. New York: Wiley. Ch. 43, pp 381-422.
34. McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb KS, Kane R, DiPino R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Hamilton M, Jacobson-Kram D, Burrows B, Walsh M. 2000. Health effects of depleted uranium on exposed Gulf War veterans. Environ Res 82: 168-180.
35. McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Jacobson-Kram D. 2001. Surveillance of depleted uranium exposed Gulf War veterans: Health effects observed in an enlarged "friendly fire" cohort. J Occup Environ Med 43: 991-1000.
36. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Handwerger B, Albertini RJ, Jacobson-Kram D, Thorne CD, Squibb KS. 2004. Health effects of depleted uranium on exposed Gulf War veterans: A 10-year follow-up. J Toxicol Environ Health Part A 67: 277-296.
37. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Albertini RJ, Gudi R, Jacobson-Kram D, Thorne CD, Squibb KS. 2006. Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int Arch Occup Environ Health 79: 11-21.
38. McDiarmid MA, Engelhardt SE, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Jacobson-Kram D, Squibb KS. 2007. Health surveillance of Gulf War I veterans exposed to depleted uranium: Updating the cohort. Health Phys 93: 60-73.
39. McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Squibb KS. 2009. Surveillance results of depleted uranium-exposed Gulf War I veterans: Sixteen years of follow-up. J Toxicol Environ Health Part A 72: 14-29.
40. McDiarmid MA, Gaitens JM, Squibb KS. In Press. Uranium and thorium. In: Rose VE, Cohrssen B, editors. Patty's Industrial Hygiene and Toxicology, 6th ed. New York: Wiley.
41. McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Gaitens JM, Kane R, Cernich A, Kaup B, Hoover D, Gaspari AA, Shvartsbeyn M, Brown L, Squibb KS. 2011. Longitudinal health surveillance in a cohort of Gulf War veterans 18 years after first exposure to depleted uranium. J Toxicol Environ Health Part A 74: 678-691.
42. Miller AC, Fuciarelli AF, Jackson WE, Ejnik EJ, Emond C, Strocko S, Hogan J, Page N, Pellmar T. 1998a. Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagen 13: 643-648.
43. Miller AC, Blakely WF, Livengood D, Whittaker T, Xu J, Ejnik JW, Hamilton MM, Parlette E, John TS, Gerstenberg HM, Hsu H. 1998b. Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ Health Perspect 106: 465-471.
44. Miller AC, Stewart M, Brooks K, Shi L, Page N. 2002. Depeted uranium-catalyzed oxidative DNA damage: Absence of significant alpha decay. J Inorg Biochem 91: 246-252.
45. Miller AC, Brooks K, Stewart M, Anderson B, Shi L, McClain D, Page N. 2003. Genomic instability in human osteoblast cells after exposure to depleted uranium: Delayed lethality and micronuclei formation. J Environ Radioact 64: 247-259.
46. Miller AC, Brooks K, Smith J, Page N. 2004. Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem 255: 247-256.
47. Miller AC, Bonait-Pellie C, Merlot RF, Michel J, Stewart M, Lison PD. 2005. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium. Mol Cell Biochem 279: 97-104.
48. Mitchel REJ, Jackson JS, Heinmeiller B. 1999. Inhaled uranium ore dust and lung cancer risk in rats. Health Phys 76: 145-155.
49. Monleau M, De Meo M, Paquet F, Chazel V, Dumenil G, Donnadieu-Claraz M. 2006. Genotoxic and inflammatory effects of depleted uranium particles inhaled by rats. Toxicol Sci 89: 287-295.
50. Montesano R, Bartsch H, Vainio H, Wilbourn J, Yamasaki H, editors. 1986. Long-Term and Short-Term Assays for Carcinogenesis-A Critical Appraisal (IARC Scientific Publications No. 83). Lyon: IARC.
51. National Research Council (NRC). 2008. Review of Toxicologic and Radiologic Risks to Military Personnel from Exposure to Depleted Uranium During and After Combat. Washington, DC: National Academy Press.
52. NHANES. 2005. Third National Report on Human Exposure to Environmental Chemicals. NCEH Publication No. 05-0570. Atlanta, GA: Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey.
53. O'Neill JP, McGinnis MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ. 1987. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagen 2: 87-94.
54. Papastefanou C. 2002. Depleted uranium in military conflicts and the impact on the environment. Health Phys 83: 280-282.
55. Parkhurst MA. 2003. Measuring aerosols generated inside armoured vehicles perforated by depleted uranium ammunition. Radiat Prot Dosimetry 105: 167-170.
56. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C. 2008. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99: 1909-1912.
57. Periyakaruppan A, Kumar F, Sarkar S, Sharma CS, Ramesh G. 2007. Uranium induces oxidative stress in lung epithelial cells. Arch Toxicol 81: 389-395.
58. Popp W, Plappert U, Muller WU, Rehn B, Schneider J, Braun A, Bauer PC, Vahrenholz C, Presek P, Brauksiepe A, Enderle G, Wust T, Bruch J, Fliedner TM, Konietzko N, Streffer C, Woitowitz HJ, Norpoth K. 2000. Biomarkers of genetic damage and inflammation in blood and bronchoalveolar lavage fluid among former German uranium miners: A pilot study. Radiat Environ Biophys 39: 275-282.
59. Samet JM. 1989. Radon and lung cancer. J Natl Cancer Inst 81: 745-758.
60. Samet JM, Pathak DR, Morgan MV, Marbury MC, Key CR, Valdivia AA. 1989. Radon progeny exposure and lung cancer risk in New Mexico U miners: A case-control study. Health Phys 56: 415-421.
61. Squibb KS, McDiarmid MA. 2006. Depleted uranium exposure and health effects in Gulf War veterans. Phil Trans R Soc B 361: 639-648.
62. Squibb KS, McDiarmid MA. 2007. Exposure and health surveillance in Gulf War veterans exposed to depleted uranium. In: Miller AC, editor. Depleted Uranium. Properties, Uses, and Health Consequences. Boca Raton, FL: CRC Press. pp 105-119.
63. StataCorp. 2009. Stata Statistical Software. College Station, TX: Stata.
64. Stearns DM, Yazzie M, Bradley AS, Coryell VH, Shelley JT, Ashby A, Asplund CS, Lantz RC. 2005. Uranyl acetate induces HPRT mutations and uranium-DNA adducts in Chinese hamster ovary EM9 cells. Mutagen 20: 417-423.
65. Tannenbaum A, editor. 1951. Toxicology of Uranium. National Nuclear Energy Series. New York: McGraw-Hill.
66. Tannenbaum A, Silverstone H, Koziol J. 1951. The distribution and excretion of uranium in mice, rats and dogs. In: Tannenbaum A, editor. Toxicology of Uranium Compounds. New York, NY: McGraw-Hill. pp 28-181.
67. The Royal Society. 2001. The Health Hazards of Depleted Uranium Munitions Part I. Policy Document 6/01. London, UK: Royal Society.
68. The Royal Society. 2002. The Health Effects of Depleted Uranium Munitions. Summary. London, UK: Royal Society.
69. Thiébault C, Carrière M, Milgram S, Simon A, Avoscan L, Gouget B. 2007. Uranium induces apoptosis and is genotoxic to normal rat kidney (NRK-52E) proximal cells. Toxicol Sci 98: 479-487.
70. Thun MJ, Baker DB, Steenland K, Smith AB, Halperin W, Berl T. 1985. Renal toxicity in uranium mill workers. Scand J Work Environ Health 11: 83-90.
71. Vainio H, Magee PN, McGregor DB, McMichael AJ, editors. 1992. Mechanisms of Carcinogenesis in rRisk Identification (IARC Scientific Publications No. 116). Lyon: IARC.
72. Vral A, Fenech M, Thierens H. 2011. The microncleus assay as a biological dosimeter of in vivo ionizing radiation exposure. Mutagen 26: 11-17.
73. Wise S, Thompson D, Aboueissa A-M, Mason MD, Wise JP. 2007. Particulate depleted uranium is cytotoxic and clastogenic to human lung cells. Chem Res Toxicol 20: 815-820.
74. Xu J, Long JS. 2005. Confidence intervals for predicted outcomes in regression models for categorical outcomes. Stata J 5: 537-559.
75. Yazzie M, Gamble SL, Civetello ER, Sterns DM. 2003. Uranyl acetate causes DNA single strand breaks in vitro in the presence of ascorbate (vitamin C). Chem Res Toxicol 16: 524-530.
76. Zaire R, Notter M, Riedel W, Thiel E. 1997. Unexpected rates of chromosomal instabilities and alterations of hormone levels in Namibian uranium miners. Radiat Res 147: 579-584.
77. Zhang L, Rothman N, Wang Y, Hayes RB, Li G, Dosemeci M, Yin S, Kolachana P, Titenko-Holland N, Smith MT. 1998. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis 9: 1955-1961.
78. Zhang L, Rothman N, Wang Y, Hayes RB, Yin S, Titenko-Holland N, Dosemeci M, Wang YZ, Kolachana P, Lu W, Xi L, Li GL, Smith MT. 1999. Benzene increases aneuploidy in the lymphocytes of exposed workers: A comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells. Environ Mol Mutagen 34: 260-268.